The Bank continues to remain the best-managed PSB on all major fronts. Analysis of its stressed assets clearly suggests that it is approaching the end of recognition of stressed loan cycle, which along with higher PCR clearly indicates sharp moderation in credit cost from FY19 onwards. Further, strong revival in loan growth along with improvement in NIMs and other income suggests continued improvement in operating profit, going forward. Hence, we expect healthy traction in earnings to continue owing to robust growth in loan book, moderate credit cost and healthy margins. We upgrade our recommendation on the stock to BUY from HOLD with a...